Abbott Laboratories Stock Swiss Exchange

Equities

ABT

US0028241000

Medical Equipment, Supplies & Distribution

Delayed Swiss Exchange 11:31:05 2024-02-19 am EST 5-day change 1st Jan Change
93 CHF -.--% Intraday chart for Abbott Laboratories -.--% -.--%
Sales 2024 * 41.7B 38B Sales 2025 * 44.75B 40.78B Capitalization 185B 169B
Net income 2024 * 5.96B 5.43B Net income 2025 * 7.17B 6.53B EV / Sales 2024 * 4.58 x
Net Debt 2024 * 5.47B 4.99B Net cash position 2025 * 913M 832M EV / Sales 2025 * 4.12 x
P/E ratio 2024 *
31.2 x
P/E ratio 2025 *
26.7 x
Employees 114,000
Yield 2024 *
2.03%
Yield 2025 *
2.17%
Free-Float 86.77%
More Fundamentals * Assessed data
Dynamic Chart
1 week
93.00
Extreme 93
93.00
1 month
93.00
Extreme 93
93.00
Current year
93.00
Extreme 93
93.00
1 year
89.00
Extreme 89
93.50
3 years
86.50
Extreme 86.5
128.00
5 years
70.00
Extreme 70
128.00
10 years
33.75
Extreme 33.75
128.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 50 14-12-31
Director of Finance/CFO 51 96-12-31
Chief Tech/Sci/R&D Officer - 89-12-31
Members of the board TitleAgeSince
Director/Board Member 69 17-02-15
Director/Board Member 63 17-06-28
Director/Board Member 65 11-12-08
More insiders
Date Price Change
24-04-25 93 -.--%
24-04-24 93 -.--%
24-04-23 93 -.--%
24-04-22 93 -.--%
24-04-19 93 -.--%

Delayed Quote Swiss Exchange, February 19, 2024 at 11:31 am EST

More quotes
Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - diagnostic systems and instruments (39.1%); - vascular devices (24.7%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - nutrition products (12.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (8.2%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc.; - other (15.9%). Net sales are distributed geographically as follows: the United States (38.5%), Germany (5.8%), China (5.6%), India (4.4%), Switzerland (4.1%), Japan (3.8%), Netherlands (2.7%) and others (35.1%).
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
25
Last Close Price
106.9 USD
Average target price
126.3 USD
Spread / Average Target
+18.22%
Consensus